These contradictory results might be explained by differences in stages of disease, treatment modalities as well as different populations, which may have different expressions of oncogenic proteins as seen for HER2 in oesophageal cancer (Lam et al, 1998; Dreilich et al, 2006). Here, ERBB2 is linked to carcinoma of esophagus.